---
title: "In September, CIFI HOLD GP's contract sales amounted to RMB 900 million"
description: "In September, CIFI HOLD GP's contract sales amounted to RMB 900 million"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/260888022.md"
published_at: "2025-10-13T11:33:27.000Z"
---

# In September, CIFI HOLD GP's contract sales amounted to RMB 900 million

In September, CIFI HOLD GP's contract sales amounted to RMB 900 million

### Related Stocks

- [00884.HK - CIFI HOLD GP](https://longbridge.com/en/quote/00884.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CIFI Holdings Avoids First Periodic Mandatory Conversion on USD4.08 Billion Convertible Bonds | CIFI Holdings (Group) Co. Ltd. has announced that it will not trigger a periodic mandatory conversion of its USD4.08 bil | [Link](https://longbridge.com/en/news/274462308.md) |
| CIFI Holdings Announces Periodic Mandatory Conversion of Mandatory Convertible Bonds | CIFI Holdings Group Co. Ltd. announced the periodic mandatory conversion of its zero coupon secured guaranteed mandatory | [Link](https://longbridge.com/en/news/274459905.md) |
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/en/news/276056763.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.